Overview
To evaluate if there is any clinical difference in patients 3.5-12kg who undergo cardiac surgery with cardiopulmonary bypass that do and do not receive blood products as part of their procedure. The main hypothesis of the study is that the patients undergoing bloodless cardiac surgery will have decreased morbidity and mortality when compared to the cohort that did receive blood as well as a shorter ICU and hospital length of stay.
Eligibility
Inclusion Criteria:
- Patient weight 3.5-12kg
- Elective and urgent cardiac surgery with cardiopulmonary bypass
- Cases within the STS STAT categories of 1-4
Exclusion Criteria:
- Patients who weigh more than 12kg or less than 3.5kg.
- Patients undergoing emergency surgery.
- STAT category 5 cases.
- Patients whose surgery does not require cardiopulmonary bypass.
- Patients presenting preoperatively in shock.
- Patients with known blood dyscrasias.